Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Denver
        • Denver Leadership
        • Denver Contacts
      • Detroit
        • Detroit Contacts
      • El Paso
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Leadership
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Leadership
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Offices
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Congressional and Public Affairs
      • Social Media Directory
  • What We Do
    • Orden público
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • Family Summit 2022
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
  • Careers
    • Special Agent
      • Contact Your Local Recruiter
      • Special Agent FAQs
      • Special Agent Job Announcements
      • What it takes to be a DEA Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Library
      • FOIA Logs and Reports
      • FOIA Additional Resources
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Search
  • Full Menu

Main Menu

  • Who We Are
  • What We Do
  • Careers
  • Resources
  • Submit A Tip
  • Get Updates
  • English
  • ES

Drug Enforcement Administration

Frank A. Tarentino III Special Agent in Charge
New York
@DEANewYorkDiv
October 04, 2019
Contact: Erin Mulvey
Phone Number: (212) 337-2906
For Immediate Release

Staten Island doctor pleads guilty to illegally distributing oxycodone

NEW YORK - United States Attorney for the Southern District of New York Geoffrey S. Berman and Special Agent in Charge Ray Donovan, of the U.S. Drug Enforcement Administration's New York Division, announced today that Carl Anderson, a state licensed doctor, pled guilty to writing medically unnecessary prescriptions for oxycodone.  Anderson pled guilty before U.S. Magistrate Judge Kevin N. Fox and will be sentenced before U.S. District Court Judge Lorna G. Schofield at a later date.

 

U.S. Attorney Geoffrey S. Berman said: “As a physician, Carl Anderson should have been the first line of defense in the ongoing opioid epidemic.  Instead, as he admitted in federal court today, in exchange for cash payments, Anderson conspired with others to dispense dangerous and addictive opiates that were being sold on the street.  He now faces serious prison time for his actions.”

 

According to allegations in the Indictment and other documents filed in federal court, as well as statements made in public court proceedings:

 

Oxycodone is a highly addictive, narcotic opioid that is used to treat severe and chronic pain conditions.  Oxycodone prescriptions are in high demand and have significant cash value to drug dealers.  In fact, oxycodone tablets can be resold on the street for thousands of dollars.  For example, 30-milligram oxycodone tablets have a current street value of approximately $30 each in New York City, with street prices even higher in other parts of the country.  A single prescription for 180 30-milligram tablets of oxycodone can net an illicit distributor $5,400 in cash or more.

 

From at least approximately 2006 until his arrest in October 2018, Anderson operated a medical clinic in Staten Island, New York, where he wrote thousands of medically unnecessary oxycodone prescriptions in exchange for cash.  Anderson prescribed large quantities of oxycodone pills to patients he knew had no legitimate medical need for the medication, including his co-defendant Arthur Grande, who sold the pills on the streets of New York.  Anderson often held “patient visits” without appointments in the middle of the night – sometimes at 3:00 or 4:00 a.m. and sometimes at his home – and required “patients” to pay $150 to $200 per prescription in cash.  Many “patients” traveled from long distances, displayed visible signs of addiction to narcotics, or were plainly not taking, and instead were selling, their pills.  When Anderson was arrested in October 2018, the DEA found over $200,000 in illicit drug proceeds in his home.

 

While pleading guilty today, Anderson admitted that he “violated [his] duties granted to [him] as a licensed physician,” “willfully turned a blind eye to . . . suspicions,” and participated in a “scheme” that “amounted to . . . diversion” of oxycodone.  As part of his guilty plea today, Anderson agreed to the forfeiture of $264,164 in drug proceeds that were seized from his home.

 

Anderson, 58, of Staten Island, pled guilty to one count of conspiring to distribute and possess with intent to distribute oxycodone.  Anderson’s co-defendant, Arthur Grande, pled guilty to the same offense on Oct. 1, 2019.  This offense carries a maximum sentence of 20 years in prison.  The maximum potential sentence is prescribed by Congress and is provided here for informational purposes only, as any sentencing of the defendant will be determined by the judge.

 

Mr. Berman praised the investigative work of the DEA Tactical Diversion Squad in New York, which comprises agents and officers from the DEA, the New York City Police Department, the New York State Police, New York State Department of Financial Services, New York National Guard and New York City Department of Investigation and New York State Department of Health Bureau of Narcotics Enforcement.  He also acknowledged the assistance of the Department of Health & Human Services. 

 

The case is being prosecuted by the Office’s Narcotics Unit.  Assistant U.S. Attorney Nicolas Roos is in charge of the prosecution. 

 

Oxycodone
  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster